Mediastinal tumor overview

Jump to navigation Jump to search

Mediastinal tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mediastinal Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mediastinal tumor overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mediastinal tumor overview

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mediastinal tumor overview

CDC on Mediastinal tumor overview

Mediastinal tumor overview in the news

Blogs on Mediastinal tumor overview

Directions to Hospitals Treating Mediastinal tumor

Risk calculators and risk factors for Mediastinal tumor overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Masses in the anterior portion of the mediastinum can include thymoma, lymphoma, and germ cell tumors including teratoma. Lung cancer typically spreads to the lymph nodes in the mediastinum.

Anterior mediastinal compartment, also known as anterosuperior compartment, is anterior to the pericardium. Masses in this area is more likely to be malignant than those in other compartments Most common masses found here include thymomas, germ cell tumors, lymphomas, thyroid tissue, and parathyroid lesions.

Anterior mediastinal tumor

Thymoma

Most common primary anterior mediastinal tumor (20%) in adults but rarely seen in children. It can be classified as lymphocytic, epithelial, or spindle cell histologies, but this is not very significant clinically. Tonofibrils seen under electron microscopy can differentiate thymoma from other tumors such as carcinoid, Hodgkin's, and seminoma. Patients are usually asymptomatic but can present with myasthenia gravis-related symptoms, substernal pain, dyspnea, or cough. Invasive tumors can produce compression effects such as superior vena cava syndrome.

Thymomas are diagnosed with CT or MRI revealing mass in anterior mediastinum.

Therapy in stage I tumors consists of surgical resection with good prognosis.

Stage II-III requires maximal resection possible followed by radiation.

Stage IV disease requires addition of cisplatin-based chemotherapy in addition to those in stage II and III.

For those with invasive thymoma, treatment is based on induction chemotherapy, surgical resection, and post-surgical radiation.

5-year survival for invasive thymoma is between 12-54% regardless of any myasthenia gravis symptoms.

Lymphoma

Secondary most common primary anterior mediastinal mass in adults. Most are seen in the anterior compartment and rest are seen in middle compartment. Hodgkin's usually present in 40-50's with nodular sclerosing type, and non-Hogdkin's in all age groups. Can also be primary mediastinal B cell lymphoma with exceptionally good prognosis [1] [2] [3]

Common symptoms include fever, weight loss, night sweats, and compressive symptoms such as pain, dyspnea, wheezing, SVC syndrome, pleural effusions.

Diagnosis usually by CT showing lobulated mass. Confirmation done by tissue biopsy of accompanying nodes if any, mediastinoscopy, mediastinotomy, or thoracotomy. FNA biopsy usually not adequate.

Treatment of mediastinal Hodgkin's involves chemotherapy and/or radiation. 5 year survival is now around 75%. Large-cell type may have somewhat better prognosis. Surgery is generally not performed because of invasive nature of tumor.

Of all cancers involving the same class of blood cell, 2% of cases are mediastinal large B cell lymphomas.[4]

References

  1. J Exp Med. 2003 Sep 15;198(6):851-62
  2. Leukemia and Lymphoma, Volume 49, Issue 6 June 2008 , pages 1050 - 1061.
  3. The Oncologist, Vol. 11, No. 5, 488-495, May 2006; doi:10.1634/theoncologist.11-5-488
  4. Turgeon, Mary Louise (2005). Clinical hematology: theory and procedures. Hagerstown, MD: Lippincott Williams & Wilkins. p. 283. ISBN 0-7817-5007-5. Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and Lymphoid Tissues. 2001, p. 2001.)


Template:WikiDoc Sources